Skip to main content
Year archive

Athira Pharma, Inc. — 2022 filings

All 90 regulatory filings released by Athira Pharma, Inc. (ATHA) in 2022, sourced directly from the official regulator.

90 Filings
2022 Period
2022 filings (90)
Filing Released Lang
FORM 4 SUBMISSION
Director's Dealing
2022-12-30 English
FORM 4 SUBMISSION
Director's Dealing
2022-12-07 English
8-K
Board/Management Information
2022-11-18 English
FORM 4 SUBMISSION
Director's Dealing
2022-11-18 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-10 English
8-K
Regulatory Filings
2022-11-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-11-01 English
FORM 4 SUBMISSION
Director's Dealing
2022-10-18 English
8-K
Regulatory Filings
2022-10-17 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-15 English
8-K
Regulatory Filings
2022-08-15 English
SC 13D/A
Major Shareholding Notification
2022-07-01 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-07-01 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-30 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-25 English
8-K
Regulatory Filings
2022-06-22 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-05-27 English
8-K
Declaration of Voting Results & Voting Rights Announcements
2022-05-24 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-17 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-17 English
DFAN 14A
Proxy Solicitation & Information Statement
2022-05-16 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-12 English
8-K
Earnings Release
2022-05-12 English
DFAN 14A
Proxy Solicitation & Information Statement
2022-05-12 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-11 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-09 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-05 English
SCHEDULE 14A INFORMATION
Proxy Solicitation & Information Statement
2022-05-05 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-05 English
DEFA14A
Proxy Solicitation & Information Statement
2022-05-05 English
DFAN 14A
Proxy Solicitation & Information Statement
2022-05-04 English
SCHEDULE DFAN14A - DEFINITIVE ADDITIONAL MATERIALS
Proxy Solicitation & Information Statement
2022-05-02 English
SCHEDULE 14A INFORMATION
Proxy Solicitation & Information Statement
2022-04-27 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-26 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-26 English
SCHEDULE 14A INFORMATION
Proxy Solicitation & Information Statement
2022-04-25 English
SCHEDULE 14A INFORMATION
Proxy Solicitation & Information Statement
2022-04-22 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-20 English
SCHEDULE 14A INFORMATION
Proxy Solicitation & Information Statement
2022-04-13 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-13 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-11 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-11 English
DFAN14A
Proxy Solicitation & Information Statement
2022-04-11 English
DEFC14A
Proxy Solicitation & Information Statement
2022-04-11 English
PREC14A
Proxy Solicitation & Information Statement
2022-04-08 English
Regulatory Filings 2022
Regulatory Filings
2022-04-06 English
DEFA14A
Proxy Solicitation & Information Statement
2022-04-05 English
DEFC14A
Proxy Solicitation & Information Statement
2022-04-05 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-01 English
PREC14A
Proxy Solicitation & Information Statement
2022-03-30 English
DEFA14A
Proxy Solicitation & Information Statement
2022-03-30 English
DFAN14A
Proxy Solicitation & Information Statement
2022-03-30 English
DEFA14A
Proxy Solicitation & Information Statement
2022-03-28 English
S-8
Capital/Financing Update
2022-03-28 English
10-K
Annual Report FY 2021
2022-03-28 English
Regulatory Filings 2022
Regulatory Filings
2022-03-25 English
PREC14A
Proxy Solicitation & Information Statement
2022-03-25 English
8-K
Earnings Release
2022-03-24 English
FORM 4 SUBMISSION
Director's Dealing
2022-03-21 English
FORM 3 SUBMISSION
Director's Dealing
2022-03-21 English
FORM 3/A SUBMISSION
Director's Dealing
2022-03-21 English
8-K
Board/Management Information
2022-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-19 English
SC 13G/A
Major Shareholding Notification
2022-02-14 English
SC 13G/A
Major Shareholding Notification
2022-02-14 English
ATHIRA PHARMA, INC.
Major Shareholding Notification
2022-02-14 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-04 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-31 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-31 English
FORM 3 SUBMISSION
Director's Dealing
2022-01-31 English
8-K
Board/Management Information
2022-01-31 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2022-01-06 English